Evidence map›Paper›PMID 31700127›Full record

ArticleScientific reports2019

ClpC affects the intracellular survival capacity of Staphylococcus aureus in non-professional phagocytic cells.

Gubesh Gunaratnam, Lorena Tuchscherr, Mohamed I Elhawy, Ralph Bertram, Janina Eisenbeis, Christian Spengler, Thomas Tschernig, Bettina Löffler, Greg A Somerville, Karin Jacobs and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Bacteria clip out damaged cells from populations.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  10. Staphylococcal ClpXP protease targets the cellular antioxidant system to eliminate fitness-compromised cells in stationary phase.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  11. Article
  12. Article
  13. Persistence ofFrontiers in microbiology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Gubesh GunaratnamInstitute of Medical Microbiology and Hygiene, Saarland University, Homburg/Saar, Germany.
Lorena TuchscherrInstitute of Medical Microbiology, Jena University Hospital, Jena, Germany.
Mohamed I ElhawyInstitute of Medical Microbiology and Hygiene, Saarland University, Homburg/Saar, Germany.
Ralph BertramInstitute of Clinical Hygiene, Medical Microbiology and Infectiology, Paracelsus Medical University, Nuremberg, Germany.ORCID http://orcid.org/0000-0003-0654-6381
Janina EisenbeisInstitute of Medical Microbiology and Hygiene, Saarland University, Homburg/Saar, Germany.
Christian SpenglerExperimental Physics, Saarland University, Saarbrucken, Germany.
Thomas TschernigInstitute of Anatomy and Cell Biology, Saarland University, Homburg/Saar, Germany.ORCID http://orcid.org/0000-0002-7788-1796
Bettina LöfflerInstitute of Medical Microbiology, Jena University Hospital, Jena, Germany.
Greg A SomervilleSchool of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.ORCID http://orcid.org/0000-0002-0991-8737
Karin JacobsExperimental Physics, Saarland University, Saarbrucken, Germany.ORCID http://orcid.org/0000-0002-2963-2533
Mathias HerrmannInstitute of Medical Microbiology and Hygiene, Saarland University, Homburg/Saar, Germany.
Markus BischoffInstitute of Medical Microbiology and Hygiene, Saarland University, Homburg/Saar, Germany. markus.bischoff@uks.eu.
Institute of Medical Microbiology and Hygiene · DESaarland University · DEJena University Hospital · DEParacelsus Medizinische Privatuniversität · DEUniversity Hospital Münster · DEUniversity of Nebraska–Lincoln · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Invasion and persistence of bacteria within host cells requires that they adapt to life in an intracellular environment. This adaptation induces bacterial stress through events such as phagocytosis and enhanced nutrient-restriction. During stress, bacteria synthesize a family of proteins known as heat shock proteins (HSPs) to facilitate adaptation and survival. Previously, we determined the Staphylococcus aureus HSP ClpC temporally alters bacterial metabolism and persistence. This led us to hypothesize that ClpC might alter intracellular survival. Inactivation of clpC in S. aureus strain DSM20231 significantly enhanced long-term intracellular survival in human epithelial (HaCaT) and endothelial (EA.hy926) cell lines, without markedly affecting adhesion or invasion. This phenotype was similar across a genetically diverse collection of S. aureus isolates, and was influenced by the toxin/antitoxin encoding locus mazEF. Importantly, MazEF alters mRNA synthesis and/or stability of S. aureus virulence determinants, indicating ClpC may act through the mRNA modulatory activity of MazEF. Transcriptional analyses of total RNAs isolated from intracellular DSM20231 and isogenic clpC mutant cells identified alterations in transcription of α-toxin (hla), protein A (spa), and RNAIII, consistent with the hypothesis that ClpC negatively affects the intracellular survival of S. aureus in non-professional phagocytic cells, via modulation of MazEF and Agr.

Indexed as

Host-Pathogen InteractionsBacterial AdhesionBacterial ProteinsCytotoxicity, ImmunologicHeat-Shock ProteinsHumansMicrobial ViabilityMutationPhagocytesStaphylococcal InfectionsStaphylococcus aureusTranscriptional ActivationVirulenceBacterial ProteinsClpC protein, BacteriaHeat-Shock Proteins

Identifiers

PMID31700127
PMCPMC6838064
OpenAlexW2985750306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.